The great regulatory catch-upMedical device manufacturers have a lot to learn from the pharmaceutical sector which, for well over a decade, Share XThe great regulatory catch-uphttps://pharmaphorum.com/views-analysis-market-access/great-regulatory-medical-device/
The shadow of Brexit on speed of accessNo-one can miss the ongoing saga that is the UK’s exit from the European Union (EU). The uncertainties Share XThe shadow of Brexit on speed of accesshttps://pharmaphorum.com/views-analysis-market-access/the-shadow-of-brexit-on-speed-of-access/
Eyeforpharma Barcelona 2019 roundupThis year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting Share XEyeforpharma Barcelona 2019 rounduphttps://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/
Rethinking drug discoveryGeorge Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change. Share XRethinking drug discoveryhttps://pharmaphorum.com/r-d/views-analysis-r-d/rethinking-drug-discovery/
Precision medicine: AZ’s Ruth March on its next stepsAstraZeneca’s senior vice-president and head of precision medicine, research & development, Ruth March, has been central to the Share XPrecision medicine: AZ’s Ruth March on its next stepshttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/astrazeneca-ruth-march-precision-medicine/
R&D round-up: Non-opioid painkiller space heats upAs the MHRA announced that it would be convening an Expert Working Group (EWG) to assess the risks Share XR&D round-up: Non-opioid painkiller space heats uphttps://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/
Innovating in clinical trial recruitmentClinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients Share XInnovating in clinical trial recruitmenthttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/havas-lynx-faze-clinical-trials/
Pharma’s apprentice army is sculpting the futureA skills gap has been threatening to knock the shine off the UK biotechnology sector’s sparkling reputation for Share XPharma’s apprentice army is sculpting the futurehttps://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-apprentice-army-is-sculpting-the-future/
eyeforpharma barcelona day threeDay three: Thursday 14 March Highlights include: Keynote addresses from Kris Sterkens, company groups chairman EMEA at Janssen, Share Xeyeforpharma barcelona day threehttps://pharmaphorum.com/views-and-analysis/eyeforpharma-barcelona-day-three/
